Optomi ยท 2 days ago
Loan IQ Tester
Optomi is partnering with a leading organization within the financial services space to seek a detail-oriented Loan IQ Tester. The ideal candidate will be responsible for testing Loan IQ application functionalities, ensuring system accuracy, and validating end-to-end workflows for syndicated loans and related financial products.
Information TechnologyRecruiting
Responsibilities
Test Planning & Execution
Develop and execute test cases, test scripts, and scenarios for Loan IQ application
Perform functional, regression, integration, and user acceptance testing (UAT)
Validate loan setup, pricing, accruals, billing, and payment processes within Loan IQ
Defect Management
Identify, document, and track defects using appropriate tools (e.g., JIRA, ALM)
Collaborate with developers and business analysts to resolve issues
Quality Assurance
Ensure compliance with business requirements and system specifications
Validate interfaces between Loan IQ and other systems (e.g., GL, reporting tools)
Documentation
Prepare detailed test reports and provide feedback to stakeholders
Maintain test artifacts and ensure traceability to requirements
Qualification
Required
Hands-on experience with Loan IQ application
Familiarity with SQL for data validation and backend testing
Knowledge of financial products, syndicated loans, and loan servicing processes
Strong understanding of SDLC and QA methodologies
Experience with test management tools (e.g., HP ALM, JIRA)
Company
Optomi
OPTOMI is an IT staffing firm that serves its consultants, clients, and employees through its consultant-focused approach.
H1B Sponsorship
Optomi has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (7)
2024 (6)
2023 (2)
2022 (5)
2021 (8)
2020 (7)
Funding
Current Stage
Late StageRecent News
2025-09-24
2024-05-31
2024-05-24
Company data provided by crunchbase